Results supported by key neuroaxonal injury biomarkers pNfH and NfL after six months of treatment AP-101 is an investigational human-derived antibody therapeutic that selectively targets the misfolded ...
"Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer ...
Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic research teams.
It's a terminal disease, currently with no cure. ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully ...
RICHMOND, Va. (WWBT) - Following the recent death of actor Eric Dane from amyotrophic lateral sclerosis, or ALS, local physicians are intensifying efforts to find a cure for the devastating ...
Veteran journalist Oren Nahari revealed he has ALS, a severe degenerative neurological disease. How many Israelis are ...
As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing ...
In March 2024, Kayla Gonzalez started having an odd sensation behind her right kneecap. At first, she didn’t think much of it. Then, the feeling started to spread. Soon, she had weakness in her calf, ...
Erik P Pioro consults for MT Pharma, which manufactures edaravone (Radicava) and for Biogen, which manufactures tofersen (Qalsody). He has received funding support for ALS research from the ALS ...
The ALS Network’s 23rd annual Inland Empire Walk and Roll to Cure ALS, formerly the Walk to Defeat ALS, will be held Oct. 19 at Miller Park Amphitheater, 17002 Arrow Blvd., Fontana. The Walk and Roll ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results